Cancer vaccines and carbohydrate epitopes

J Heimburg-Molinaro, M Lum, G Vijay, M Jain… - Vaccine, 2011 - Elsevier
Tumor-associated carbohydrate antigens (TACA) result from the aberrant glycosylation that
is seen with transformation to a tumor cell. The carbohydrate antigens that have been found …

Mucin-type O-glycosylation and its potential use in drug and vaccine development

MA Tarp, H Clausen - Biochimica et Biophysica Acta (BBA)-General …, 2008 - Elsevier
Mucin-type O-glycans are found on mucins as well as many other glycoproteins. The
initiation step in synthesis is catalyzed by a large family of polypeptide GalNAc-transferases …

A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity

C Welinder, B Baldetorp, C Borrebaeck… - …, 2011 - academic.oup.com
Abstract The Tn antigen (GalNAc α-O-Ser/Thr) is heterogeneously synthesized by a variety
of tumors and contains an epitope defined by lectins and antibodies as a cluster of αGalNAc …

Calix[4]arene Decorated with Four Tn Antigen Glycomimetic Units and P3CS Immunoadjuvant: Synthesis, Characterization, and Anticancer Immunological Evaluation

C Geraci, GML Consoli, E Galante… - Bioconjugate …, 2008 - ACS Publications
A novel anticancer vaccine candidate built on a nonpeptidic scaffold has been synthesized.
Four S-Tn tumor-associated glycomimetic antigens have been clustered onto a calix [4] …

Early-stage loss of GALNT6 predicts poor clinical outcome in colorectal cancer

M Ogawa, A Tanaka, K Namba, J Shia, JY Wang… - Frontiers in …, 2022 - frontiersin.org
Colorectal adenocarcinomas arise from luminal lining epithelium of the colorectal tract which
is covered with highly glycosylated mucins. Mucin O-glycosylation is initiated by a family of …

Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems

R Sunasee, CK Adokoh, J Darkwa… - Expert Opinion on Drug …, 2014 - Taylor & Francis
Introduction: Carbohydrates are key participants in many biological processes including
reproduction, inflammation, signal transmission and infection. Their biocompatibility and …

A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell–lymphatic endothelium interaction

C Danussi, A Coslovi, C Campa, MT Mucignat… - …, 2009 - academic.oup.com
Malignant transformation of epithelial cells is frequently associated with the alteration of
glycosylation pathways. Tn is a common tumor-associated carbohydrate antigen present in …

Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses

T Freire, R Lo-Man, S Bay, C Leclerc - Journal of Biological Chemistry, 2011 - ASBMB
The Tn antigen (α-GalNAc-O-Ser/Thr) is one of the most specific human cancer-associated
structures. This antigen, together with mucins, the major carriers of O-glycosylated tumor …

Glycopeptide dendrimers, Part III—a review: use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases

P Niederhafner, M Reiniš, J Šebestík… - Journal of Peptide …, 2008 - Wiley Online Library
Glycopeptide dendrimers containing different types of tumor associated‐carbohydrate
antigens (TN, TF, sialyl‐TN, sialyl‐TF, sialyl‐Lex, sialyl‐Lea etc.) were used in diagnosis and …

Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant

T Freire, X Zhang, E Dériaud… - Blood, The Journal …, 2010 - ashpublications.org
In vivo targeting of C-type lectin receptors is an effective strategy for increasing antigen
uptake and presentation by dendritic cells (DCs). To induce efficient immune response …